Redcare Pharmacy NV (XSWX:RDC) Long-Term Debt: CHF0 Mil (As of Mar. 2026)


XSWX:RDC Redcare Pharmacy NV XSWX:RDC
48 GF Score
Price CHF60.95
GF Value CHF143.20
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Redcare Pharmacy NV Long-Term Debt?

Redcare Pharmacy NV XSWX:RDC 48 Long-Term Debt is CHF0 Mil as of Mar. 2026. GuruFocus rates XSWX:RDC with a GF Score™ of 48/100 and a GF Value™ of CHF143.20 (Significantly Undervalued). The stock has 2 warning signs investors should review.

Redcare Pharmacy NV's Long-Term Debt for the quarter that ended in Mar. 2026 was CHF0 Mil.

Redcare Pharmacy NV's quarterly Long-Term Debt increased from Sep. 2025 (CHF0 Mil) to Dec. 2025 (CHF244 Mil) but then declined from Dec. 2025 (CHF244 Mil) to Mar. 2026 (CHF0 Mil).

Redcare Pharmacy NV's annual Long-Term Debt increased from Dec. 2023 (CHF194 Mil) to Dec. 2024 (CHF195 Mil) and increased from Dec. 2024 (CHF195 Mil) to Dec. 2025 (CHF244 Mil).

Redcare Pharmacy NV  (XSWX:RDC) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Redcare Pharmacy NV Long-Term Debt Related Terms

Redcare Pharmacy NV Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Redcare Pharmacy NV's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Redcare Pharmacy NV Long-Term Debt Chart

Redcare Pharmacy NV Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 212.27 217.17 193.70 195.22 244.39

Redcare Pharmacy NV Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 244.39 0.00
XSWX:RDC
48GF Score
Redcare Pharmacy NV XSWX:RDC
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of CHF0 Mil mean?
Redcare Pharmacy NV (XSWX:RDC) has a Long-Term Debt of CHF0 Mil as of Mar. 2026.
Is Redcare Pharmacy NV's Long-Term Debt too high?
Redcare Pharmacy NV's current Long-Term Debt is CHF0 Mil. Overall, Redcare Pharmacy NV has a GF Score™ of 48/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Redcare Pharmacy NV's Long-Term Debt compare to competitors?
Redcare Pharmacy NV's Long-Term Debt of CHF0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Healthcare Providers & Services company?
A good Long-Term Debt depends on the Healthcare Providers & Services industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Redcare Pharmacy NV's current Long-Term Debt is CHF0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Redcare Pharmacy NV stock overvalued right now?
Based on GuruFocus' analysis, Redcare Pharmacy NV (XSWX:RDC) is currently considered Significantly Undervalued. The stock's GF Value™ is CHF143.20, compared to a current price of CHF60.95 — trading 57.4% below its estimated fair value. The current Long-Term Debt is CHF0 Mil. Redcare Pharmacy NV's overall GF Score™ is 48/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Redcare Pharmacy NV (XSWX:RDC), the current Long-Term Debt is CHF0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Redcare Pharmacy NV (XSWX:RDC) Overvalued in 2026?

Based on GuruFocus' analysis, Redcare Pharmacy NV stock appears to be undervalued. The current stock price of CHF60.95 is trading 57.4% below its estimated GF Value™ of CHF143.20. GuruFocus considers Redcare Pharmacy NV to be Significantly Undervalued.

Key valuation signals for XSWX:RDC:

  • Long-Term Debt: CHF0 Mil
  • GF Value™: CHF143.20 vs. price of CHF60.95 (57.4% below fair value)
  • GF Score™: 48/100 with 2 warning signs

No single metric tells the full story. See the XSWX:RDC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Redcare Pharmacy NV Business Description

Address Erik de Rodeweg 11/13, Sevenum, ZH, NLD, 5975 WD
Redcare Pharmacy NV is an online pharmacy business for prescription and nonprescription (over-the-counter) pharmaceuticals, beauty and personal care products (BPC) and food supplements. Besides OTC, nutritional supplements, beauty and personal care products as well as an extensive assortment of health-related products in all markets, the company also provides prescription drugs for customers in Germany, Switzerland and the Netherlands. It operates in two segments, namely DACH segment that includes sales in Germany, Austria and Switzerland; and the International segment that includes sales across Belgium, the Netherlands, France and Italy. The DACH segment accounts for the majority of the revenue.
48GF Score

Get the complete analysis for XSWX:RDC

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF60.95
Price
CHF143.20
GF Value